back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-09-27 16:24 Tx date 2019-09-24 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-1,282.88
-1,688 vol $0.76 each |
15,391 | |
| Filed 2019-09-27 16:18 Tx date 2019-09-24 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,357
+5,733 vol $0.76 each |
17,079 | |
| Filed 2019-09-27 16:18 Tx date 2019-09-24 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
$-4,357.08
-5,733 vol $0.76 each |
996 | |
| Filed 2019-03-19 Tx date 2019-03-15 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-1,254.96
-996 vol $1.26 each |
11,346 | |
| Filed 2019-03-19 Tx date 2019-03-15 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,357
+1,871 vol $1.26 each |
12,342 | |
| Filed 2019-03-19 Tx date 2019-03-15 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
$-2,357.46
-1,871 vol $1.26 each |
6,729 | |
| Filed 2018-12-10 Tx date 2018-12-06 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
$-14,400
-11,250 vol $1.28 each |
8,600 | |
| Filed 2018-12-10 Tx date 2018-12-06 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-4,240.64
-3,313 vol $1.28 each |
10,471 | |
| Filed 2018-12-10 Tx date 2018-12-06 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$14,400
+11,250 vol $1.28 each |
13,784 | |
| Filed 2018-08-27 Tx date 2018-08-22 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
136,665 | |
| Filed 2018-03-26 Tx date 2018-03-15 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
56 - Grant of rights
|
+8,600 vol |
19,850 | |
| Filed 2018-03-26 Tx date 2018-03-15 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
86,665 | |
| Filed 2017-12-11 Tx date 2017-12-06 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,750 vol |
3,750 | |
| Filed 2017-12-11 Tx date 2017-12-06 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,049.28
-1,216 vol $3.33 each |
2,534 | |
| Filed 2017-12-11 Tx date 2016-12-16 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
37 - Stock split or consolidation
|
-60,000 vol |
15,000 | |
| Filed 2017-12-11 Tx date 2017-12-06 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
57 - Exercise of rights
|
-3,750 vol |
11,250 | |
| Filed 2017-12-11 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-03 Tx date 2017-05-01 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
46,665 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+26,665 vol |
26,665 | |
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-09 Tx date 2016-11-29 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-12-09 Tx date 2016-12-06 |
$NVLN
Novelion Therapeutics Inc. |
Chan, Barbara
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Stock Unit
56 - Grant of rights
|
+75,000 vol |
75,000 |